Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):263-277. doi: 10.1016/j.bbcan.2018.03.003. Epub 2018 Mar 21.
Biochim Biophys Acta Rev Cancer. 2018.
PMID: 29574128
Review.